Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease

被引:1770
作者
Berger, EA [1 ]
Murphy, PM
Farber, JM
机构
[1] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA
[3] NIAID, Clin Invest Lab, NIH, Bethesda, MD 20892 USA
关键词
AIDS; genetics; G protein-coupled receptors; pathogenesis; therapeutics;
D O I
10.1146/annurev.immunol.17.1.657
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In addition to CD4, the human immunodeficiency virus (HIV) requires a coreceptor for entry into target cells. The chemokine receptors CXCR4 and CCR5, members of the G protein-coupled receptor superfamily, have been identified as the principal coreceptors for T cell line-tropic and macrophage-tropic HIV-1 isolates, respectively. The updated coreceptor repertoire includes numerous members, mostly chemokine receptors and related orphans. These discoveries provide a new framework for understanding critical features of the basic biology of HIV-1, including the selective tropism of individual viral variants for different CD4(+) target cells and the membrane fusion mechanism governing virus entry. The coreceptors also provide molecular perspectives on central puzzles of HIV-1 disease, including the selective transmission of macrophage-tropic variants, the appearance of T cell line-tropic variants in many infected persons during progression to AIDS, and differing susceptibilities of individuals to infection and disease progression. Genetic findings have yielded major insights into the in vivo roles of individual coreceptors and their ligands; of particular importance is the discovery of an inactivating mutation in the CCR5 gene which, in homozygous form, confers strong resistance to HIV-1 infection. Beyond providing new perspectives on fundamental aspects of HIV-1 transmission and pathogenesis, the coreceptors suggest new avenues for developing novel therapeutic and preventative strategies to combat the AIDS epidemic.
引用
收藏
页码:657 / 700
页数:44
相关论文
共 235 条
  • [81] CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia
    He, JL
    Chen, YZ
    Farzan, M
    Choe, HY
    Ohagen, A
    Gartner, S
    Busciglio, J
    Yang, XY
    Hofmann, W
    Newman, W
    Mackay, CR
    Sodroski, J
    Gabuzda, D
    [J]. NATURE, 1997, 385 (6617) : 645 - 649
  • [82] Apoptosis of CD8+ T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
    Herbein, G
    Mahlknecht, U
    Batliwalla, F
    Gregersen, P
    Pappas, T
    Butler, J
    O'Brien, WA
    Verdin, E
    [J]. NATURE, 1998, 395 (6698) : 189 - 194
  • [83] Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1α is mediated by the chemokine receptor CXCR4
    Hesselgesser, J
    Taub, D
    Baskar, P
    Greenberg, M
    Hoxie, J
    Kolson, DL
    Horuk, R
    [J]. CURRENT BIOLOGY, 1998, 8 (10) : 595 - 598
  • [84] CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons
    Hesselgesser, J
    HalksMiller, M
    DelVecchio, V
    Peiper, SC
    Hoxie, J
    Kolson, DL
    Taub, D
    Horuk, R
    [J]. CURRENT BIOLOGY, 1997, 7 (02) : 112 - 121
  • [85] Dissociation of the signalling and antiviral properties of SDF-1-derived small peptides
    Heveker, N
    Montes, M
    Germeroth, L
    Amara, A
    Trautmann, A
    Alizon, M
    Schneider-Mergener, J
    [J]. CURRENT BIOLOGY, 1998, 8 (07) : 369 - 376
  • [86] Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor
    Hill, CM
    Deng, HK
    Unutmaz, D
    Kewalramani, VN
    Bastiani, L
    Gorny, MK
    ZollaPazner, S
    Littman, DR
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (09) : 6296 - 6304
  • [87] CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status
    Hoffman, TL
    MacGregor, RR
    Burger, H
    Mick, R
    Doms, RW
    Collman, RG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (04) : 1093 - 1096
  • [88] HIV type I envelope determinants for use of the CCR2b, CCR3, STRL33, and APJ coreceptors
    Hoffman, TL
    Stephens, EB
    Narayan, O
    Doms, RW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (19) : 11360 - 11365
  • [89] The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains
    Horuk, R
    Hesselgesser, J
    Zhou, YQ
    Faulds, D
    Halks-Miller, M
    Harvey, S
    Taub, D
    Samson, M
    Parmentier, M
    Rucker, J
    Doranz, BJ
    Doms, RW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 386 - 391
  • [90] Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: A candidate for chemotherapeutic and microbicidal application
    Howard, OMZ
    Oppenheim, JJ
    Hollingshead, MG
    Covey, JM
    Bigelow, J
    McCormack, JJ
    Buckheit, RW
    Clanton, DJ
    Turpin, JA
    Rice, WG
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (13) : 2184 - 2193